Ranitidine and Cancidas drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Cancidas (caspofungin acetate). Common drug interactions include aspergillosis among females and multi-organ failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Cancidas. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Cancidas?

Cancidas has active ingredients of caspofungin acetate. eHealthMe is studying from 4,879 Cancidas users. Check the latest studies of Cancidas.

On Aug, 05, 2026

26 people who take Ranitidine and Cancidas together, and have interactions are studied.

Ranitidine and Cancidas drug interactions.

What are the common drug interactions of Ranitidine and Cancidas, by gender? *:

female:

Aspergillosis (an infection caused by a fungus called aspergillus)
Drug ineffective
Hepatic failure (liver failure)
Pulmonary haemorrhage (acute bleeding from the lung)
Renal failure (kidney dysfunction)
Bacterial infection
Oedema (fluid collection in tissue)
Rash
Swelling
Drug level above therapeutic

male:

Multi-organ failure (multisystem organ failure)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Back pain
Congestive cardiomyopathy (weakening of heart muscle)
Diastolic dysfunction
Dyspnoea exertional (breathlessness or shortness of breath)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Osteonecrosis (death of bone)
Respiratory failure (inadequate gas exchange by the respiratory system)
Systolic dysfunction (impaired ventricular contraction)

What are the common drug interactions of Ranitidine and Cancidas, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Pyrexia (fever)
Central nervous system haemorrhage (bleeding in brain and surrounding)
Lethargy (tiredness)
Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Pneumonia
Vasculitic rash (inflammation of a blood vessel or blood vessels with rashes under the skin)
Activated partial thromboplastin time prolonged
Acute respiratory distress syndrome
Cardiac arrest

10-19:

Arthralgia (joint pain)
Back pain
Congestive cardiomyopathy (weakening of heart muscle)
Diastolic dysfunction
Dyspnoea exertional (breathlessness or shortness of breath)
Osteonecrosis (death of bone)
Systolic dysfunction (impaired ventricular contraction)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug level above therapeutic

20-29:

n/a

30-39:

Aspergillosis (an infection caused by a fungus called aspergillus)
Drug ineffective
Hepatic failure (liver failure)
Pulmonary haemorrhage (acute bleeding from the lung)
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute lymphocytic leukaemia (cancer of the white blood cells)
Disease progression
Febrile neutropenia (fever with reduced white blood cells)
Multi-organ failure (multisystem organ failure)

40-49:

Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Device related infection
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Multi-organ failure (multisystem organ failure)
Stenotrophomonas infection
Blood glucose increased
Pneumonia primary atypical (primary atypical pneumonia which were probably caused by mycoplasma pneumoniae)
Renal failure acute (rapid kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

Oedema (fluid collection in tissue)
Rash
Swelling
Blood alkaline phosphatase nos increased
Hyperbilirubinaemia (excess of bilirubin in the blood)
Multi-organ failure (multisystem organ failure)

60+:

Bacterial infection
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypokalaemia (low potassium)
Inflammation
Pulmonary oedema (fluid accumulation in the lungs)
Renal impairment (severely reduced kidney function)
Device related infection

What are the existing conditions these people have? *

Hypokalemia (low potassium): 7 people, 26.92%
Infection: 7 people, 26.92%
Cytomegalovirus Infection: 6 people, 23.08%
Stenotrophomonas Infection: 6 people, 23.08%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 23.08%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 6 people, 23.08%
Cardiac Fibrillation (uncontrolled muscle contraction of heart): 6 people, 23.08%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 23.08%
Mucosal Inflammation (infection of mucous membrane): 6 people, 23.08%
Acute Kidney Failure: 6 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Cancidas?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously